278 related articles for article (PubMed ID: 28355272)
1. Vitamin D receptor gene is epigenetically altered and transcriptionally up-regulated in multiple sclerosis.
Ayuso T; Aznar P; Soriano L; Olaskoaga A; Roldán M; Otano M; Ajuria I; Soriano G; Lacruz F; Mendioroz M
PLoS One; 2017; 12(3):e0174726. PubMed ID: 28355272
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation-related vitamin D receptor insensitivity in breast cancer.
Marik R; Fackler M; Gabrielson E; Zeiger MA; Sukumar S; Stearns V; Umbricht CB
Cancer Biol Ther; 2010 Jul; 10(1):44-53. PubMed ID: 20431345
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-22 Level in Patients with Multiple Sclerosis and Its Relationship with Vitamin D and Vitamin D Receptor Levels.
Khedr AMB; Shaker OG; Hassan A; Hussein M; Kamal YS; Azouz TA
Neuroimmunomodulation; 2022; 29(2):128-134. PubMed ID: 34537762
[TBL] [Abstract][Full Text] [Related]
4. The expression of VDR mRNA but not NF-κB surprisingly decreased after vitamin D treatment in multiple sclerosis patients.
Shirvani-Farsani Z; Kakhki MP; Gargari BN; Doosti R; Moghadasi AN; Azimi AR; Behmanesh M
Neurosci Lett; 2017 Jul; 653():258-263. PubMed ID: 28576565
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D receptor polymorphisms and 25-hydroxyvitamin D in a group of Sicilian multiple sclerosis patients.
Agnello L; Scazzone C; Ragonese P; Salemi G; Lo Sasso B; Schillaci R; Musso G; Bellia C; Ciaccio M
Neurol Sci; 2016 Feb; 37(2):261-7. PubMed ID: 26506927
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the human vitamin D3 receptor promoter in breast cancer cells is mediated through Sp1 sites.
Wietzke JA; Ward EC; Schneider J; Welsh J
Mol Cell Endocrinol; 2005 Jan; 230(1-2):59-68. PubMed ID: 15664452
[TBL] [Abstract][Full Text] [Related]
7. Expression of vitamin D receptor and metabolizing enzymes in multiple sclerosis-affected brain tissue.
Smolders J; Schuurman KG; van Strien ME; Melief J; Hendrickx D; Hol EM; van Eden C; Luchetti S; Huitinga I
J Neuropathol Exp Neurol; 2013 Feb; 72(2):91-105. PubMed ID: 23334593
[TBL] [Abstract][Full Text] [Related]
8. Immunomodulatory effects of Vitamin D in multiple sclerosis.
Correale J; Ysrraelit MC; Gaitán MI
Brain; 2009 May; 132(Pt 5):1146-60. PubMed ID: 19321461
[TBL] [Abstract][Full Text] [Related]
9. Molecular network of chromatin immunoprecipitation followed by deep sequencing-based vitamin D receptor target genes.
Satoh J; Tabunoki H
Mult Scler; 2013 Jul; 19(8):1035-45. PubMed ID: 23401126
[TBL] [Abstract][Full Text] [Related]
10. Expression analysis of vitamin D receptor-associated long noncoding RNAs in patients with relapsing-remitting multiple sclerosis.
Naiini MR; Saeidi K; Azarian A; Bahramzadeh K; Nazari-Robati M
Bratisl Lek Listy; 2024; 125(2):107-112. PubMed ID: 38219064
[TBL] [Abstract][Full Text] [Related]
11. Novel modulating effects of PKC family genes on the relationship between serum vitamin D and relapse in multiple sclerosis.
Lin R; Taylor BV; Simpson S; Charlesworth J; Ponsonby AL; Pittas F; Dwyer T; van der Mei IA
J Neurol Neurosurg Psychiatry; 2014 Apr; 85(4):399-404. PubMed ID: 23868949
[TBL] [Abstract][Full Text] [Related]
12. Association study on two vitamin D receptor gene polymorphisms and vitamin D metabolites in multiple sclerosis.
Smolders J; Damoiseaux J; Menheere P; Tervaert JW; Hupperts R
Ann N Y Acad Sci; 2009 Sep; 1173():515-20. PubMed ID: 19758194
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D-related gene expression profiles in immune cells of patients with relapsing remitting multiple sclerosis.
Smolders J; Thewissen M; Theunissen R; Peelen E; Knippenberg S; Menheere P; Cohen Tervaert JW; Hupperts R; Damoiseaux J
J Neuroimmunol; 2011 Jun; 235(1-2):91-7. PubMed ID: 21507492
[TBL] [Abstract][Full Text] [Related]
14. LINE-1 Hypermethylation in Serum Cell-Free DNA of Relapsing Remitting Multiple Sclerosis Patients.
Dunaeva M; Derksen M; Pruijn GJM
Mol Neurobiol; 2018 Jun; 55(6):4681-4688. PubMed ID: 28707075
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D, vitamin D binding protein, vitamin D receptor levels and cardiac dysautonomia in patients with multiple sclerosis: a cross-sectional study.
Aktürk T; Turan Y; Tanik N; Karadağ ME; Sacmaci H; Inan LE
Arq Neuropsiquiatr; 2019 Dec; 77(12):848-854. PubMed ID: 31939581
[TBL] [Abstract][Full Text] [Related]
16. Differential methylation at
Maltby VE; Lea RA; Sanders KA; White N; Benton MC; Scott RJ; Lechner-Scott J
Clin Epigenetics; 2017; 9():71. PubMed ID: 28729889
[TBL] [Abstract][Full Text] [Related]
17. 1,25-Dihydroxyvitamin D3 up-regulates the renal vitamin D receptor through indirect gene activation and receptor stabilization.
Healy KD; Frahm MA; DeLuca HF
Arch Biochem Biophys; 2005 Jan; 433(2):466-73. PubMed ID: 15581603
[TBL] [Abstract][Full Text] [Related]
18. Methylation patterns of cell-free plasma DNA in relapsing-remitting multiple sclerosis.
Liggett T; Melnikov A; Tilwalli S; Yi Q; Chen H; Replogle C; Feng X; Reder A; Stefoski D; Balabanov R; Levenson V
J Neurol Sci; 2010 Mar; 290(1-2):16-21. PubMed ID: 20064646
[TBL] [Abstract][Full Text] [Related]
19. Methylation status of the CpG islands in vitamin D and calcium-sensing receptor gene promoters does not explain the reduced gene expressions in parathyroid adenomas.
Varshney S; Bhadada SK; Sachdeva N; Arya AK; Saikia UN; Behera A; Rao SD
J Clin Endocrinol Metab; 2013 Oct; 98(10):E1631-5. PubMed ID: 23913941
[TBL] [Abstract][Full Text] [Related]
20. The expression and methylation status of vitamin D receptor gene in Behcet's disease.
Shirvani SS; Nouri M; Sakhinia E; Babaloo Z; Jadideslam G; Shahriar A; Farhadi J; Khabbazi A
Immun Inflamm Dis; 2019 Dec; 7(4):308-317. PubMed ID: 31709782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
